Wei Teng
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
- Periodontics top 5%
- Oral microbiology and periodontitis research
Papers in
- Hepatology 40
- Hepatocellular Carcinoma Treatment and Prognosis 30
- Hepatitis C virus research 11
- Epidemiology 34
- Liver Disease Diagnosis and Treatment 26
- Hepatitis B Virus Studies 14
- Co-authors
- Wen‐Juei Jeng (25 shared papers)Chun‐Yen Lin (32 shared papers)I‐Shyan Sheen (23 shared papers)Wei‐Ting Chen (22 shared papers)Chen‐Chun Lin (16 shared papers)Xueping Yu (10 shared papers)Xiaohong Dai (11 shared papers)Shi‐Ming Lin (12 shared papers)
- Journals
- European Journal of Gastroenterology & Hepatology (3 papers)Scientific Reports (3 papers)American Journal of Cancer Research (3 papers)Liver Cancer (3 papers)Cancers (3 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Wei Teng
79 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 121
- Hepatology 347
- Periodontics 83
- Epidemiology 314
- Neurology 108
- Neurology 52
Countries citing papers authored by Wei Teng
This map shows the geographic impact of Wei Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Teng more than expected).
Fields of papers citing papers by Wei Teng
This network shows the impact of papers produced by Wei Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Teng. The network helps show where Wei Teng may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Teng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 99 | |
| 2 | 2015 | 83 | |
| 3 | 2021 | 46 | |
| 4 | 2021 | 44 | |
| 5 | 2017 | 41 | |
| 6 | 2022 | 39 | |
| 7 | 2021 | 36 | |
| 8 | 2021 | 34 | |
| 9 | 2014 | 27 | |
| 10 | 2014 | 23 | |
| 11 | 2021 | 23 | |
| 12 | 2017 | 22 | |
| 13 | 2021 | 21 | |
| 14 | 2016 | 21 | |
| 15 | 2022 | 21 | |
| 16 | 2018 | 19 | |
| 17 | Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma. | 2021 | 18 |
| 18 | 2022 | 17 | |
| 19 | 2018 | 17 | |
| 20 | 2018 | 16 |
About Wei Teng
Wei Teng is a scholar working on Hepatology, Epidemiology, Molecular Biology, Neurology and Oncology, having authored 85 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Liver Disease Diagnosis and Treatment (26 papers), Hepatitis B Virus Studies (14 papers), Intracerebral and Subarachnoid Hemorrhage Research (11 papers), Hepatitis C virus research (11 papers), Cancer, Lipids, and Metabolism (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Neurological Disease Mechanisms and Treatments (5 papers). The work is most often cited by research in Hepatology (347 citations), Periodontics (83 citations), Epidemiology (314 citations), Neurology (108 citations) and Neurology (52 citations). Wei Teng has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Wen‐Juei Jeng, Chun‐Yen Lin, I‐Shyan Sheen, Wei‐Ting Chen, Chen‐Chun Lin, Xueping Yu, Xiaohong Dai, Shi‐Ming Lin, Jianxing Wang and Lei Song. Their work appears in journals such as European Journal of Gastroenterology & Hepatology, Scientific Reports, American Journal of Cancer Research, Liver Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.